AVITA Medical, Inc. Stock Australian S.E.
Equities
AVH
AU000000AVH4
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.37 AUD | -0.42% |
|
-2.07% | -44.76% |
Jul. 02 | Avita Medical Appoints Chief Legal and Compliance Officer | MT |
Jul. 01 | Avita Medical Names Chief Legal, Compliance Officer | MT |
Sales 2024 * | 113M 76.2M | Sales 2025 * | 158M 106M | Capitalization | 301M 202M |
---|---|---|---|---|---|
Net income 2024 * | -66M -44.4M | Net income 2025 * | -32M -21.53M | EV / Sales 2024 * | 2.34 x |
Net cash position 2024 * | 36.16M 24.32M | Net Debt 2025 * | 2.27M 1.53M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
-4.42
x | P/E ratio 2025 * |
-9.91
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.08% |
Latest transcript on AVITA Medical, Inc.
1 day | -0.42% | ||
1 week | -2.07% | ||
Current month | -2.07% | ||
1 month | -17.42% | ||
3 months | -48.59% | ||
6 months | -40.00% | ||
Current year | -44.76% |
![Extreme 2.34](/images/extremecours_fleche.png)
![Extreme 2.34](/images/extremecours_fleche.png)
![Extreme 2.34](/images/extremecours_fleche.png)
![Extreme 2.34](/images/extremecours_fleche.png)
![Extreme 1.28](/images/extremecours_fleche.png)
![Extreme 1.28](/images/extremecours_fleche.png)
![Extreme 0.92](/images/extremecours_fleche.png)
Date | Price | Change | Volume |
---|---|---|---|
24-07-04 | 2.37 | -0.42% | 204 929 |
24-07-03 | 2.38 | -0.83% | 234,605 |
24-07-02 | 2.4 | -1.64% | 460,966 |
24-07-01 | 2.44 | +0.83% | 216,122 |
24-06-28 | 2.42 | +0.41% | 231,829 |
Delayed Quote Australian S.E., July 04, 2024 at 02:10 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
+41.02% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- RCEL Stock
- AVH Stock